demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only
COVID 19 hospitalized
COVID-19 severe or critically
anticoagulant
anticoagulant, curative dose REMAP-CAP, ACTIV-4a, ATTACC ... COVID-PACT
anticoagulation, intermediate prophylactic dose INSPIRATION
heparin at therapeutic dose ACTIV-4a ... REMAP-CAP Anticoagulation ATTACC ...

12 studies excluded by filtering options 1

5071 Tang, 2020 1133not a RCThigh risk of bias
5355 Paranjpe, 2020 1134not a RCThigh risk of bias
5404 Tremblay, 2020 1130not a RCTrisk of bias not avaialble
5441 Ayerbe, 2020 1130not a RCTrisk of bias not avaialble
5777 Bousquet, 2020 1130not a RCTrisk of bias not avaialble
5777 Bousquet, 2020 1130not a RCTrisk of bias not avaialble
6283 Lynn, 2020 0130selection pending
6393 Rossi, 2020 1130not a RCTrisk of bias not avaialble
6396 Russo, 2020 1130not a RCTrisk of bias not avaialble
6404 Trinh, 2020 1130not a RCTrisk of bias not avaialble
6406 Gonzalez-Porras, 2020 1130not a RCTrisk of bias not avaialble
6406 Gonzalez-Porras, 2020 1130not a RCTrisk of bias not avaialble